Nerve Mapping Advantage Sentio MMG provides a nerve mapping and avoidance system for minimally invasive spine surgery. The technology helps reduce nerve injury risk while enabling quicker, safer implant placement. Sales opportunities exist with spine surgeons, hospital systems, and ambulatory surgery centers seeking to improve patient safety, reduce variability, and shorten OR times.

Hospital Surgeon Targets Target buyers include spine surgeons and hospital procurement teams, especially in centers of excellence and high-volume MIS spine programs. As a small company, Sentio could benefit from an account-based approach focusing on top hospitals, OR directors, and spine surgeons who are early adopters of advanced nerve-sparing tech.

Partnership Opportunities Partnership opportunities with medical device manufacturers, distributors, or integrated OR solution providers could accelerate market adoption. Joint ventures or distribution agreements would help expand reach beyond Michigan and scale faster.

Clinical Validation Needs Clinical validation and education will support purchasing decisions. Potential customers will want case studies, peer-reviewed data, and pilot programs demonstrating reduced nerve injury risk and workflow efficiency. Sentio should pursue clinical collaborations, registries, and publications to build credibility.

Marketing Education Demand Marketing and education demand exists to raise surgeon awareness and demand for nerve mapping technology. Investment in medical education content, surgical technique videos, webinars, and thought leadership can build demand and shorten sales cycles. Engage KOLs and plan conference presence to drive adoption.